GQOClass II
Antisera, Cf, Herpesvirus Hominis 1,2
21 CFR 866.3305 / Microbiology
GQO is the FDA product code for Antisera, Cf, Herpesvirus Hominis 1,2, a class II device type, regulated under 21 CFR 866.3305. As of , FDA records hold 16 510(k) clearances under this code, the most recent dated , and one recall.
Classification record
- Product code
- GQO
- Device name
- Antisera, Cf, Herpesvirus Hominis 1,2
- Regulation
- 21 CFR 866.3305
- Device class
- Class II
- Review panel
- Microbiology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 16
- Ingested recalls
- 1
Clearances, product code GQO
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1979 | 1 |
| 1985 | 6 |
| 1986 | 3 |
| 1987 | 2 |
| 1988 | 2 |
| 1989 | 2 |
Applicants with the most clearances
Product code GQO| Applicant | Clearances |
|---|---|
| Amico Lab, Inc. | 2 |
| Armkel, LLC | 2 |
| Clinical Sciences, Inc. | 2 |
| Electro-Nucleonics, Inc. | 2 |
| Behring Diagnostics, Inc. | 1 |
| Bion Ent., Ltd. | 1 |
| Disease Detection International, Inc. | 1 |
| Electro-Nucleonics Laboratories, Inc. | 1 |
| Isolab, Inc. | 1 |
| Microbiological Research Corp. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
